1. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient
- Author
-
Sébastien Viel, Guillaume Monneret, Céline Bernet, Florence Ader, Donatien de Marignan, Fabienne Venet, Morgane Gossez, Emilie Frobert, Rémy Coudereau, Florent Wallet, Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Compassionate Use Trials ,Male ,medicine.medical_specialty ,Antifungal Agents ,Coronavirus disease 2019 (COVID-19) ,Critical Illness ,[SDV]Life Sciences [q-bio] ,Pneumonia, Viral ,Immunology ,Immune monitoring ,Severe Acute Respiratory Syndrome ,Betacoronavirus ,Fatal Outcome ,Viral genetics ,Lymphopenia ,Correspondence ,medicine ,Humans ,Immunologic Factors ,Immunology and Allergy ,Intensive care medicine ,Pandemics ,Viral immunology ,Aged ,SARS-CoV-2 ,Critically ill ,business.industry ,Interleukin-7 ,COVID-19 ,Pneumonia, Ventilator-Associated ,Compassionate Use ,Interleukin ,Diagnostic markers ,Acute Kidney Injury ,Respiration, Artificial ,Anti-Bacterial Agents ,Intensive Care Units ,Infectious Diseases ,Coronavirus Infections ,business ,Biomarkers - Abstract
International audience; No abstract available
- Published
- 2020